FORM 8-K

Company

Outlook Therapeutics, Inc.

Filed

October 31, 2017

Period of Report

October 26, 2017

Accession Number

0001571049-17-008378

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →